- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to this latest study, the 2020 growth of CRISPR and CRISPR-Associated (Cas) Genes will have significant change from previous year. By the most conservative estimates of global CRISPR and CRISPR-Associated (Cas) Genes market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 698.3 million in 2019. Over the next five years the CRISPR and CRISPR-Associated (Cas) Genes market will register a 41.5% CAGR in terms of revenue, the global market size will reach US$ 2799 million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of CRISPR and CRISPR-Associated (Cas) Genes market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Genome Editing
Genetic Engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Caribou Biosciences
Addgene
CRISPR THERAPEUTICS
Merck KGaA
Mirus Bio LLC
Editas Medicine
Takara Bio USA
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
GE Healthcare Dharmacon
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Consumption 2016-2026
2.1.2 CRISPR and CRISPR-Associated (Cas) Genes Consumption CAGR by Region
2.2 CRISPR and CRISPR-Associated (Cas) Genes Segment by Type
2.2.1 Genome Editing
2.2.2 Genetic Engineering
2.2.3 gRNA Database/Gene Librar
2.2.4 CRISPR Plasmid
2.2.5 Human Stem Cells
2.2.6 Genetically Modified Organisms/Crops
2.2.7 Cell Line Engineering
2.3 CRISPR and CRISPR-Associated (Cas) Genes Sales by Type
2.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2016-2021)
2.3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue and Market Share by Type (2016-2021)
2.3.3 Global CRISPR and CRISPR-Associated (Cas) Genes Sale Price by Type (2016-2021)
2.4 CRISPR and CRISPR-Associated (Cas) Genes Segment by Application
2.4.1 Biotechnology Companies
2.4.2 Pharmaceutical Companies
2.4.3 Academic Institutes
2.4.4 Research and Development Institutes
2.5 CRISPR and CRISPR-Associated (Cas) Genes Sales by Application
2.5.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sale Market Share by Application (2016-2021)
2.5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue and Market Share by Application (2016-2021)
2.5.3 Global CRISPR and CRISPR-Associated (Cas) Genes Sale Price by Application (2016-2021)
3 Global CRISPR and CRISPR-Associated (Cas) Genes by Company
3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Company
3.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Company (2019-2021)
3.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Company (2019-2021)
3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company
3.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2019-2021)
3.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2019-2021)
3.3 Global CRISPR and CRISPR-Associated (Cas) Genes Sale Price by Company
3.4 Global Manufacturers CRISPR and CRISPR-Associated (Cas) Genes Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers CRISPR and CRISPR-Associated (Cas) Genes Product Location Distribution
3.4.2 Players CRISPR and CRISPR-Associated (Cas) Genes Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 CRISPR and CRISPR-Associated (Cas) Genes by Region
4.1 Global CRISPR and CRISPR-Associated (Cas) Genes by Region
4.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Region
4.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region
4.2 Americas CRISPR and CRISPR-Associated (Cas) Genes Sales Growth
4.3 APAC CRISPR and CRISPR-Associated (Cas) Genes Sales Growth
4.4 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Growth
4.5 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Sales Growth
5 Americas
5.1 Americas CRISPR and CRISPR-Associated (Cas) Genes Sales by Country
5.1.1 Americas CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2016-2021)
5.1.2 Americas CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2016-2021)
5.2 Americas CRISPR and CRISPR-Associated (Cas) Genes Sales by Type
5.3 Americas CRISPR and CRISPR-Associated (Cas) Genes Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CRISPR and CRISPR-Associated (Cas) Genes Sales by Region
6.1.1 APAC CRISPR and CRISPR-Associated (Cas) Genes Sales by Region (2016-2021)
6.1.2 APAC CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region (2016-2021)
6.2 APAC CRISPR and CRISPR-Associated (Cas) Genes Sales by Type
6.3 APAC CRISPR and CRISPR-Associated (Cas) Genes Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe CRISPR and CRISPR-Associated (Cas) Genes by Country
7.1.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2016-2021)
7.1.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2016-2021)
7.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Type
7.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes by Country
8.1.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2016-2021)
8.1.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2016-2021)
8.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Sales by Type
8.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 CRISPR and CRISPR-Associated (Cas) Genes Distributors
10.3 CRISPR and CRISPR-Associated (Cas) Genes Customer
11 Global CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
11.1 Global CRISPR and CRISPR-Associated (Cas) Genes Forecast by Region
11.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Forecast by Regions (2021-2026)
11.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global CRISPR and CRISPR-Associated (Cas) Genes Forecast by Type
11.7 Global CRISPR and CRISPR-Associated (Cas) Genes Forecast by Application
12 Key Players Analysis
12.1 Caribou Biosciences
12.1.1 Caribou Biosciences Caribou Biosciences Company Information
12.1.2 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Offered
12.1.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Caribou Biosciences Main Business Overview
12.1.5 Caribou Biosciences Latest Developments
12.2 Addgene
12.2.1 Addgene Company Information
12.2.2 Addgene CRISPR and CRISPR-Associated (Cas) Genes Product Offered
12.2.3 Addgene CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Addgene Main Business Overview
12.2.5 Addgene Latest Developments
12.3 CRISPR THERAPEUTICS
12.3.1 CRISPR THERAPEUTICS Company Information
12.3.2 CRISPR THERAPEUTICS CRISPR and CRISPR-Associated (Cas) Genes Product Offered
12.3.3 CRISPR THERAPEUTICS CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 CRISPR THERAPEUTICS Main Business Overview
12.3.5 CRISPR THERAPEUTICS Latest Developments
12.4 Merck KGaA
12.4.1 Merck KGaA Company Information
12.4.2 Merck KGaA CRISPR and CRISPR-Associated (Cas) Genes Product Offered
12.4.3 Merck KGaA CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Merck KGaA Main Business Overview
12.4.5 Merck KGaA Latest Developments
12.5 Mirus Bio LLC
12.5.1 Mirus Bio LLC Company Information
12.5.2 Mirus Bio LLC CRISPR and CRISPR-Associated (Cas) Genes Product Offered
12.5.3 Mirus Bio LLC CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Mirus Bio LLC Main Business Overview
12.5.5 Mirus Bio LLC Latest Developments
12.6 Editas Medicine
12.6.1 Editas Medicine Company Information
12.6.2 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product Offered
12.6.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Editas Medicine Main Business Overview
12.6.5 Editas Medicine Latest Developments
12.7 Takara Bio USA
12.7.1 Takara Bio USA Company Information
12.7.2 Takara Bio USA CRISPR and CRISPR-Associated (Cas) Genes Product Offered
12.7.3 Takara Bio USA CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Takara Bio USA Main Business Overview
12.7.5 Takara Bio USA Latest Developments
12.8 Thermo Fisher Scientific
12.8.1 Thermo Fisher Scientific Company Information
12.8.2 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product Offered
12.8.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Thermo Fisher Scientific Main Business Overview
12.8.5 Thermo Fisher Scientific Latest Developments
12.9 Horizon Discovery Group
12.9.1 Horizon Discovery Group Company Information
12.9.2 Horizon Discovery Group CRISPR and CRISPR-Associated (Cas) Genes Product Offered
12.9.3 Horizon Discovery Group CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Horizon Discovery Group Main Business Overview
12.9.5 Horizon Discovery Group Latest Developments
12.10 Intellia Therapeutics
12.10.1 Intellia Therapeutics Company Information
12.10.2 Intellia Therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product Offered
12.10.3 Intellia Therapeutics CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Intellia Therapeutics Main Business Overview
12.10.5 Intellia Therapeutics Latest Developments
12.11 GE Healthcare Dharmacon
12.11.1 GE Healthcare Dharmacon Company Information
12.11.2 GE Healthcare Dharmacon CRISPR and CRISPR-Associated (Cas) Genes Product Offered
12.11.3 GE Healthcare Dharmacon CRISPR and CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 GE Healthcare Dharmacon Main Business Overview
12.11.5 GE Healthcare Dharmacon Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. CRISPR and CRISPR-Associated (Cas) Genes Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Genome Editing
Table 3. Major Players of Genetic Engineering
Table 4. Major Players of gRNA Database/Gene Librar
Table 5. Major Players of CRISPR Plasmid
Table 6. Major Players of Human Stem Cells
Table 7. Major Players of Genetically Modified Organisms/Crops
Table 8. Major Players of Cell Line Engineering
Table 9. Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016-2021) & (K Units)
Table 10. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2016-2021)
Table 11. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2016-2021) & ($ million)
Table 12. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2016-2021)
Table 13. Global CRISPR and CRISPR-Associated (Cas) Genes Sale Price by Type (2016-2021)
Table 14. Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2016-2021) & (K Units)
Table 15. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2016-2021)
Table 16. Global CRISPR and CRISPR-Associated (Cas) Genes Value by Application (2016-2021)
Table 17. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2016-2021)
Table 18. Global CRISPR and CRISPR-Associated (Cas) Genes Sale Price by Application (2016-2021)
Table 19. Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Company (2019-2021) & (K Units)
Table 20. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Company (2019-2021)
Table 21. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2019-2021) ($ Millions)
Table 22. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2019-2021)
Table 23. Global CRISPR and CRISPR-Associated (Cas) Genes Sale Price by Company (2019-2021)
Table 24. Key Manufacturers CRISPR and CRISPR-Associated (Cas) Genes Producing Area Distribution and Sales Area
Table 25. Players CRISPR and CRISPR-Associated (Cas) Genes Products Offered
Table 26. CRISPR and CRISPR-Associated (Cas) Genes Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global CRISPR and CRISPR-Associated (Cas) Genes Sales by Region (2016-2021) (K Units)
Table 30. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Region (2016-2021)
Table 31. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region (2016-2021) & ($ Millions)
Table 32. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region (2016-2021)
Table 33. Americas CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2016-2021) & (K Units)
Table 34. Americas CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Country (2016-2021)
Table 35. Americas CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2016-2021) & ($ Millions)
Table 36. Americas CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Country (2016-2021)
Table 37. Americas CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016-2021) & (K Units)
Table 38. Americas CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2016-2021)
Table 39. Americas CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2016-2021) & (K Units)
Table 40. Americas CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2016-2021)
Table 41. APAC CRISPR and CRISPR-Associated (Cas) Genes Sales by Region (2016-2021) & (K Units)
Table 42. APAC CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Region (2016-2021)
Table 43. APAC CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region (2016-2021) & ($ Millions)
Table 44. APAC CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region (2016-2021)
Table 45. APAC CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016-2021) & (K Units)
Table 46. APAC CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2016-2021)
Table 47. APAC CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2016-2021) & (K Units)
Table 48. APAC CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2016-2021)
Table 49. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2016-2021) & (K Units)
Table 50. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Country (2016-2021)
Table 51. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2016-2021) & ($ Millions)
Table 52. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Country (2016-2021)
Table 53. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016-2021) & (K Units)
Table 54. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2016-2021)
Table 55. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2016-2021) & (K Units)
Table 56. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2016-2021)
Table 57. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Sales by Country (2016-2021) & (K Units)
Table 58. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Country (2016-2021)
Table 59. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2016-2021) & ($ Millions)
Table 60. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Country (2016-2021)
Table 61. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Sales by Type (2016-2021) & (K Units)
Table 62. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type (2016-2021)
Table 63. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Sales by Application (2016-2021) & (K Units)
Table 64. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2016-2021)
Table 65. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Forecast by Type (2021-2026) & (K Units)
Table 66. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share Forecast by Type (2021-2026)
Table 67. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 68. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share Forecast by Type (2021-2026)
Table 69. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Forecast by Application (2021-2026) & (K Units)
Table 70. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share Forecast by Application (2021-2026)
Table 71. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 72. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share Forecast by Application (2021-2026)
Table 73. Caribou Biosciences Basic Information, CRISPR and CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors
Table 74. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 75. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 76. Caribou Biosciences Main Business
Table 77. Caribou Biosciences Latest Developments
Table 78. Addgene Basic Information, CRISPR and CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors
Table 79. Addgene CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 80. Addgene CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 81. Addgene Main Business
Table 82. Addgene Latest Developments
Table 83. CRISPR THERAPEUTICS Basic Information, CRISPR and CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors
Table 84. CRISPR THERAPEUTICS CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 85. CRISPR THERAPEUTICS CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 86. CRISPR THERAPEUTICS Main Business
Table 87. CRISPR THERAPEUTICS Latest Developments
Table 88. Merck KGaA Basic Information, CRISPR and CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck KGaA CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 90. Merck KGaA CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 91. Merck KGaA Main Business
Table 92. Merck KGaA Latest Developments
Table 93. Mirus Bio LLC Basic Information, CRISPR and CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors
Table 94. Mirus Bio LLC CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 95. Mirus Bio LLC CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 96. Mirus Bio LLC Main Business
Table 97. Mirus Bio LLC Latest Developments
Table 98. Editas Medicine Basic Information, CRISPR and CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors
Table 99. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 100. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 101. Editas Medicine Main Business
Table 102. Editas Medicine Latest Developments
Table 103. Takara Bio USA Basic Information, CRISPR and CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors
Table 104. Takara Bio USA CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 105. Takara Bio USA CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 106. Takara Bio USA Main Business
Table 107. Takara Bio USA Latest Developments
Table 108. Thermo Fisher Scientific Basic Information, CRISPR and CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors
Table 109. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 110. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 111. Thermo Fisher Scientific Main Business
Table 112. Thermo Fisher Scientific Latest Developments
Table 113. Horizon Discovery Group Basic Information, CRISPR and CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors
Table 114. Horizon Discovery Group CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 115. Horizon Discovery Group CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 116. Horizon Discovery Group Main Business
Table 117. Horizon Discovery Group Latest Developments
Table 118. Intellia Therapeutics Basic Information, CRISPR and CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors
Table 119. Intellia Therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 120. Intellia Therapeutics CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 121. Intellia Therapeutics Main Business
Table 122. Intellia Therapeutics Latest Developments
Table 123. GE Healthcare Dharmacon Basic Information, CRISPR and CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors
Table 124. GE Healthcare Dharmacon CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 125. GE Healthcare Dharmacon CRISPR and CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 126. GE Healthcare Dharmacon Main Business
Table 127. GE Healthcare Dharmacon Latest Developments
List of Figures
Figure 1. Picture of CRISPR and CRISPR-Associated (Cas) Genes
Figure 2. CRISPR and CRISPR-Associated (Cas) Genes Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. CRISPR and CRISPR-Associated (Cas) Genes Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Genome Editing
Figure 10. Product Picture of Genetic Engineering
Figure 11. Product Picture of gRNA Database/Gene Librar
Figure 12. Product Picture of CRISPR Plasmid
Figure 13. Product Picture of Human Stem Cells
Figure 14. Product Picture of Genetically Modified Organisms/Crops
Figure 15. Product Picture of Cell Line Engineering
Figure 16. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type in 2020
Figure 17. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2016-2021)
Figure 18. CRISPR and CRISPR-Associated (Cas) Genes Consumed in Biotechnology Companies
Figure 19. Global CRISPR and CRISPR-Associated (Cas) Genes Market: Biotechnology Companies (2016-2021) & (K Units)
Figure 20. CRISPR and CRISPR-Associated (Cas) Genes Consumed in Pharmaceutical Companies
Figure 21. Global CRISPR and CRISPR-Associated (Cas) Genes Market: Pharmaceutical Companies (2016-2021) & (K Units)
Figure 22. CRISPR and CRISPR-Associated (Cas) Genes Consumed in Academic Institutes
Figure 23. Global CRISPR and CRISPR-Associated (Cas) Genes Market: Academic Institutes (2016-2021) & (K Units)
Figure 24. CRISPR and CRISPR-Associated (Cas) Genes Consumed in Research and Development Institutes
Figure 25. Global CRISPR and CRISPR-Associated (Cas) Genes Market: Research and Development Institutes (2016-2021) & (K Units)
Figure 26. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application (2016-2021)
Figure 27. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application in 2020
Figure 28. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market by Company in 2020 ($ Million)
Figure 29. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company in 2020
Figure 30. Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Regions (2016-2021)
Figure 31. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region in 2020
Figure 32. Americas CRISPR and CRISPR-Associated (Cas) Genes Sales 2016-2021 (K Units)
Figure 33. Americas CRISPR and CRISPR-Associated (Cas) Genes Revenue 2016-2021 ($ Millions)
Figure 34. APAC CRISPR and CRISPR-Associated (Cas) Genes Sales 2016-2021 (K Units)
Figure 35. APAC CRISPR and CRISPR-Associated (Cas) Genes Revenue 2016-2021 ($ Millions)
Figure 36. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales 2016-2021 (K Units)
Figure 37. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue 2016-2021 ($ Millions)
Figure 38. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Sales 2016-2021 (K Units)
Figure 39. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue 2016-2021 ($ Millions)
Figure 40. Americas CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Country in 2020
Figure 41. Americas CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Country in 2020
Figure 42. Americas CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type in 2020
Figure 43. Americas CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application in 2020
Figure 44. United States CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth 2016-2021 ($ Millions)
Figure 45. Canada CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth 2016-2021 ($ Millions)
Figure 46. Mexico CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth 2016-2021 ($ Millions)
Figure 47. Brazil CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth 2016-2021 ($ Millions)
Figure 48. APAC CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Region in 2020
Figure 49. APAC CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Regions in 2020
Figure 50. APAC CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type in 2020
Figure 51. APAC CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application in 2020
Figure 52. China CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth 2016-2021 ($ Millions)
Figure 53. Japan CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth 2016-2021 ($ Millions)
Figure 54. Korea CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth 2016-2021 ($ Millions)
Figure 55. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth 2016-2021 ($ Millions)
Figure 56. India CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth 2016-2021 ($ Millions)
Figure 57. Australia CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth 2016-2021 ($ Millions)
Figure 58. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Country in 2020
Figure 59. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Country in 2020
Figure 60. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type in 2020
Figure 61. Europe CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application in 2020
Figure 62. Germany CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth 2016-2021 ($ Millions)
Figure 63. France CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth 2016-2021 ($ Millions)
Figure 64. UK CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth 2016-2021 ($ Millions)
Figure 65. Italy CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth 2016-2021 ($ Millions)
Figure 66. Russia CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth 2016-2021 ($ Millions)
Figure 67. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Country in 2020
Figure 68. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Country in 2020
Figure 69. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Type in 2020
Figure 70. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Application in 2020
Figure 71. Egypt CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth 2016-2021 ($ Millions)
Figure 72. South Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth 2016-2021 ($ Millions)
Figure 73. Israel CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth 2016-2021 ($ Millions)
Figure 74. Turkey CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth 2016-2021 ($ Millions)
Figure 75. GCC Country CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth 2016-2021 ($ Millions)
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Please feel free to write an email to us or to use our electronic ticketing system.
